COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,591 Articles (22,905 medRxiv, 8,686 bioRxiv)

Most recent first Previous |  Page 1497: Articles 14961-14970  | Next

Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
Logue, J., Johnson, R., Patel, N., Zhou, B., Maciejewski, S., Zhou, H., Portnoff, A., Tian, J.-H., McGrath, M., Haupt, R., Weston, S., Hammod, H., Guebre-Xabier, M., Dillen, C., Plested, J., Cloney-Clark, S., Greene, A., Massare, M., Glenn, G., Smith, G., Frieman, M.
10.1101/2021.06.08.447631 — Posted: 2021-06-09
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies.
Spencer, A. J., Morris, S., Ulaszewska, M., Powers, C., Kaliath, R., Bissett, C. D., Truby, A., Thakur, N., Newman, J., Allen, E. R., Lui, C., Dejnirattisai, W., Mongkolsapaya, J., Davies, H., Donnellan, F. R., Pulido, D., Peacock, T. P., Barclay, W. S., Bright, H., Ren, K., Screaton, G., McTammy, P., Bailey, D., Gilbert, S. C., Lambe, T.
10.1101/2021.06.08.447308 — Posted: 2021-06-09
Percolation across households in mechanistic models of non-pharmaceutical interventions in SARS-CoV-2 disease dynamics
Franco, C., Ferreira, L. S., Sudbrack, V., Borges, M. E., Poloni, S., Prado, P. I., White, L. J., Aguas, R., Kraenkel, R. A., Coutinho, R. M.
10.1101/2021.06.07.21258403 — Posted: 2021-06-09
Operationalizing a routine wastewater monitoring laboratory for SARS-CoV-2
Kantor, R. S., Greenwald, H. D., Kennedy, L. C., Hinkle, A., Harris-Lovett, S., Metzger, M., Thornton, M., Paluba, J., Nelson, K. L.
10.1101/2021.06.06.21258431 — Posted: 2021-06-09
The importance of time post-vaccination in determining the decrease in vaccine efficacy against SARS-CoV-2 variants of concern
Bar-On, Y. M., Noor, E., Gottlieb, N., Sigal, A., Milo, R.
10.1101/2021.06.06.21258429 — Posted: 2021-06-09
Financial Meltdown in Swing Hospitals during the COVID-19 Outbreak
Takaku, R., Yokoyama, I.
10.1101/2021.06.06.21258442 — Posted: 2021-06-09
WHAT ABOUT USING SNIFFIN STICKS 12 SCREENING TEST TO IDENTIFY POST-COVID-19 OLFACTORY DISORDERS?
VANDERSTEEN, C., PAYNE, M., DUMAS, L. E., PLONKA, A., D'ANDREA, G., CHIRIO, D., DEMONCHY, E., RISSO, K., ASKENAZY, F. G., GUEVARA, N., CASTILLO, L., MANERA, V., GROS, A.
10.1101/2021.06.06.21258430 — Posted: 2021-06-09
g-CXR-Net: A Graphic Application for the Rapid Recognition of SARS-CoV-2 from Chest X-Rays
Gatti, D. L.
10.1101/2021.06.06.21258428 — Posted: 2021-06-09
Post-COVID-19 Perceived Stigma-Discrimination Scale: Psychometric Development and Evaluation
Cassiani-Miranda, C. A., Pedrozo-Pupo, J. C., Campo-Arias, A.
10.1101/2021.06.06.21258253 — Posted: 2021-06-09
Response of Unvaccinated US Adults to Official Information About the Pause in Use of the Johnson & Johnson-Janssen COVID-19 Vaccine
Mishra, V., Dexter, J. P.
10.1101/2021.06.08.21258558 — Posted: 2021-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).